Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1761-1765

  Steller, Michael A ^a   Delgado, Cynthia H ^a   Bartels, Christopher J ^a   Woodworth, Craig D ^a   Zou, Zhiqiang ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; UTERINE CERVIX CARCINOMA;

BASE SEQUENCE; CELL DIVISION; CLONE CELLS; DNA PRIMERS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KINETICS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; THIONUCLEOTIDES; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0029913170     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Maruo, T., Yamasaki, M., Ladines-Llave, C. A., and Mochizuki, M. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium. Cancer (Phila.), 69: 1182-1187, 1992.
2. Pietrzkowski, Z., Wernicke, D., Porcu, P., Jameson, B. A., and Baserga, R. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1 Cancer Res., 52. 6447-6451, 1992.
3. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
4. Pietrzkowski, Z , Sell, C., Lammers, R., Ullrich, A., and Baserga, R. Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol. Cell Biol , 12: 3883-3889, 1992.
5. DeAngelis, T., Ferber, A., and Baserga, R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol., 164: 214-221, 1995.
6. Yoshinouchi, M., Miura, M., Gaozza, E., Li, S. W., and Baserga, R. Basic fibroblast growth factor stimulates DNA synthesis in cells overexpressing the insulin-like growth factor-I receptor. Mol Endocrinol., 7: 1161-1168, 1993.
7. Macaulay, V.M. Insulin-like growth factors and cancer. Br. J. Cancer, 65: 311-320, 1992.
8. Coppola, D., Ferber, A., Miura, M., Sell, C., D'Ambrosio, C., Rubin, R., and Baserga, R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol., 14: 4588-4595, 1994.
9. Steller, M. A., Delgado, C. H., and Zou, Z. Insulin-like growth factor-2 mediates epidermal growth factor induced mitogenesis in cervical cancer cells. Proc Natl. Acad. Sci. USA, 92: 11970-11974, 1995
10. Woodworth, C. D., Bowden, P. E., Doniger, J., Pirisi, L., Barnes, W., Lancaster, W. D., and DiPaolo, J. A. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA Cancer Res., 48: 4620-4628, 1988.
11. Sekyi-Otu, A., Bell, R. S., Ohashi, C., Pollak, M., and Andrulis, I. L. Insulin-like growth factor I (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res., 55: 129-134, 1995.
12. Lowe, W. L , Jr., Roberts, C. T., Jr., LeRoith, D., Rojeski, M. T., Merimee, T. J., Fui, S. T., Keen, H., Arnold, D., Mersey, J., and Gluzman, S. Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger nbonucleic acid. J. Clin. Endocrinol. Metab., 69: 1153-1159, 1989.
13. Bosch, F. X , Manos, M. M., Munoz, N., Sherman, M., Jansen, A M , Peto, J., Schiffman, M. H , Moreno, V., Kurman, R., and Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group [see comments]. J. Natl. Cancer Inst , 87: 796-802, 1995.
14. Sell, C., Rubini, M , Rubin, R., Liu, J P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking Type I insulin-like growth factor receptor. Proc. Natl. Acad. Sci USA, 90: 11217-11221, 1993
15. Kaleko, M., Rutter, W J , and Miller A. D. Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10: 464-473, 1990.
16. Prager, D. Li, H. L., Asa, S , and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl Acad Sci. USA, 91: 2181-2815, 1994.
17. Christofori, G , Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumongenesis. Nature (Lond.), 369: 414-418, 1994
18. Sell, C , Baserga, R., and Rubin, R Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995
19. Baserga, R , Porcu, P , Rubini, M , and Sell, C. Cell cycle control by the IGF-1 receptor and its ligands Adv. Exp Med Biol., 343. 105-112, 1993.
20. Rubini, M., Werner, H., Gandini, E., Roberts, C T., Jr , LeRoith, D., and Baserga, R. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp Cell Res., 211. 374-379, 1994.
21. Falco, J. P., Taylor, W. G., Di Fiore, P P., Weissman, B E., and Aaronson, S. A. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. Oncogene, 2: 573-578, 1988.
22. Pater, M. M., and Pater, A Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix Virology, 145: 313-318, 1985.
23. DeChiara, T. M., Efstratiadis, A., and Robertson, E. J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (Lond), 345. 78-80, 1990.
24. Enberg, G., and Hall, K. Immunoreactive IGF-II in serum of healthy subjects and patients with growth hormone disturbances and uraemia. Acta Endocrinol. (Copenh.), 107: 164-170, 1984.
25. Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., and Hintz, R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth facyor-II transgenic mice. J. Biol. Chem., 269: 13779-13784, 1994.
26. Cullen, K. J., Lippman, M. E., Chow, D., Hill, S., Rosen, N., and Zwiebel, J. A. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol., 6: 91-100, 1992.
27. Lagrange, J. L., Francoual, M., Formento, J. L., Del Guidice, P., Bensadoun, R. J., Teissier, E., Ettore, F., Gillet, J. Y., Namer, M., and Milano, G Demonstration and characterization of EGF receptors in cancer of the uterine cervix. Bull. Cancer (Paris), 80: 219-224, 1993.
28. Liu, D., Zong, C. S., and Wang, L. H. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. J. Virol., 67: 6835-6840, 1993.
29. Surmacz, E., Sell, C., Swantek, J., Kato, H., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Exp. Cell Res., 218. 370-380, 1995.
30. Baserga, R. Oncogenes and the strategy of growth factors Cell, 79: 927-930, 1994.